In the United States about 5%-8% of the population is affected by an autoimmune disorder. Other reports, however, estimate a higher prevalence of various types of autoimmune disorders due to complex ...

Autoimmune disorders occur when the body’s immune system cannot differentiate between cells that are its own and pathogens. Consequently, the body’s immune system attacks itself causing inflammation ...

Immune disorders are some of the hardest to detect and most difficult to treat. Now Carilion Clinic and the joint medical ...

Kymera Therapeutics, Inc. (KYMR) just reported positive results from its phase 1 healthy volunteer study using KT-621. The purpose of this clinical candidate is to develop it as an oral STAT6 protein ...

Welcome to the Allergy and Immunology Fellowship Program. This university-based training program offers a world-class academic environment that fosters clinical excellence, research innovation and ...

Inflammatory diseases contain a broad spectrum of immune-mediated conditions, including autoimmune, autoinflammatory, allergic, dermatologic, ...

Accurate measurement of HMGB-1, neopterin and sIL-2R supports reliable assessment of immune activation across clinical and ...

The Department of Pediatrics at Dr. Rajendra Prasad Government Medical College (DRPGMC), Tanda, marked the International Day of Immunology with an academic programme highlighting the growing ...

Cartilage-hair hypoplasia (CHH) is an autosomal recessive disorder characterised by skeletal dysplasia, short stature, and a variable degree of immunodeficiency. The condition arises principally from ...

A significant overlap has been identified in the functionalities of genes associated with immune and metabolic disorders, suggesting a fundamental frameshift is needed in our understanding of the two.

Three years after AbbVie stood at the edge of a major patent cliff with the loss of exclusivity for immunology ...

PARIS — France's Sanofi has agreed to buy US-based Blueprint Medicines Corp. for over $9 billion to boost its position in rare immunology diseases, in what would be the biggest health care deal in ...